Group items tagged

The 1980s brought in a new way of capturing volatile molecules of virtually any scented objects in the form of 'Headspace Technology' which completely revolutionized the industry. Headspace works like a camera and captures snapshots of the scent's components and allows them to be recreated in the laboratory.

The study estimates the Vascular Graft market size for 2018 and projects its demand till 2023. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the demand side include research scientists, Vascular Graft specialists, laboratory technicians, and R&D professionals of pharmaceutical and biotechnology companies and academic research institutes.

An experimental device made from layered filter paper is helping Rice University bioengineers study calcifying heart diseases. The filter paper is structured in a way that mimics the layering of aortic heart valves, recreating the means by which cells spread through cardiac tissue in a laboratory setting. It may not look much like a heart valve, but in practice it simulates the proliferation process in the same way.

PRODUCT DESCRIPTION LARGO CREAM IN PAKISTAN WHAT IS LARGO 1-From the oldest name in the medicine industry, Inverma brings you Largo! 2-Largo cream for men is a fast-acting formula that will effectively increase your erection capacity. 3- Largo for men is easily absorbed into the penis and ensures maximum results within a matter of days. DOES LARGO WORK? The answer to that question is yes! Thousands of men across the globe have used Largo to increase the size of their penis. It is one of the original enhancement creams on the market, and is a trusted solution to all of your penis problems. This is the reason why Largo is one of our best selling products ever. Maximise your length, girth AND maintain stronger, firmer erections! IS LARGO SAFE TO USE? Largo is produced by Inverma under laboratory conditions for ensured safety and efficiency. Largo is safe to use, highly effective and long-lasting. LARGO CREAM FEATURES- Enhancement In Men Power Increase In Size Of Men S Organ Enhancement In Ejaculation Timing Big, Long And Thick Organ On Permanent Basis Made Of Precious Herbs With Combination Of Modern Formulas No Side Effects Increase In Rate And Duration Of Erection It Is Absorbed In The Skin So Increasing The Blood Flow In Vessels Increase In Semen Volume Tags & Keywords Largo Cream Cream Openteleshop Largo Cream, Largo Cream Cream, Largo Cream Cream Price In Pakistan, Largo Cream Cream Review, Largo Cream Cream Price, Largo Cream Cream Use, Largo Cream Cream In Pakistan, Largo Cream Enlargement Cream, Penis Enlargement Medicines, Largo Cream In Lahore, Largo Cream In Karachi, Largo Cream In Islambad,Largo Cream In Pakistan, Largo Cream Enlargement Cream In Pakistan Lahore Karachi, Penis Enlargement Medicines, Penis Enlargement Cream, Men Power, Largo Cream Price In Pakistan. LARGO CREAM PRICE IN PAKISTAN:1999/PKR

PET Preforms for mineral water bottling industries. No other company in Kuwait offers you so extensive a range. No wonder that the end product is carefully finished, smooth, with flash-free necks, tailless and uniformed wall thickness with high clarity and low 'AA' level. The Pet preform are so designed that while blowing, the material gets distributed evenly, thereby making absolutely sturdy bottles. GPI has full-fledged laboratory ensuring strict tests at every stage. The designing department provides newer, effective and creative solutions, catering to every requirement of the customers.

Indian drugmaker Dr Reddy's Laboratories will launch its generic version of Merck's antiviral Covid-19 pill, molnupiravir, and price it at 35 rupees ($0.4693) per capsule, a company spokesperson said on Tuesday (January 4). The overall cost for a patient treated with a 5-day course of 40 capsules of the generic drug, to be sold under brand name 'Molflu', will come up to 1,400 rupees ($18.77). In comparison, the treatment with Merck's pill in the United States costs $700. "Molflu is expected to be available from early next week in pharmacies throughout (India) with particular focus on states with high caseload of Covid-19," the company spokesperson said. India last week gave emergency use approval to along with two vaccines, as the country braces for a possible spike in coronavirus cases due to the rapidly spreading Omicron variant.

The Indian government has suspended manufacturing in over 40 pharmaceutical companies based on a risk-based assessment conducted earlier in the year across 162 firms, according to the data provided by Union Health Minister Mansukh Mandaviya in Parliament on Thursday (Aug. 10). "Overall, a sum of 143 show-cause notices has been issued," Mandaviya said. There have been numerous recent incidents involving accusations from foreign countries regarding the contamination of syrups, eye drops, and ointments manufactured in India. Countries such as the Gambia, Uzbekistan, and Cameroon have linked the deaths of 70, 18, and six children, respectively, to cough syrups contaminated in India. Licenses for specific products have been either temporarily suspended or fully revoked for an additional 66 companies. In one case, an FIR has been registered, and in 21 cases, warning letters have been issued following inspections by both the Central Drugs Standard Control Organization and State authorities, the Minister added. Meanwhile, the Indian government has mandated rigorous testing for cough syrups before export. Starting June 1, any cough syrup must possess a government laboratory-issued certificate of analysis before being exported, the government said in a notice dated May 22.

National Institute for Health and Care Excellence (NICE)'s diagnostic advisory committee has recommended the use of HM-JACKarc or OC-Sensor quantitative faecal immunochemical tests (FIT) in a draft guidance release for consultation on Wednesday (5 July). Under existing NICE guidance, FIT was already offered to some people presenting to primary care with symptoms suggestive of colorectal cancer, while others were immediately referred on the suspected cancer pathway. The new draft guidance will now see everyone receive a FIT. A sample is sent in the post to a laboratory where the amount of blood in the faeces is measured. The results are usually available within a week and people with 10 or more micrograms of haemoglobin in their faeces should then be referred for further investigation. Further assessment using colonoscopy, or CT colonography, is required to diagnose cancer. The tests cost between £4 and £5 per sample, and can correctly identify about 9 out of 10 people with colorectal cancer. The committee agreed it is important that GPs can refer people for colonoscopy without a positive FIT result if they think it is necessary and where symptoms persist. The institute believes that the recommendation of the tests should reduce the number of unnecessary colonoscopies, thus freeing up appointments for more non-urgent referrals. This should lead to 50% fewer referrals for urgent colonoscopies being made by GPs in primary care settings each year.

India will make tests mandatory for cough syrups before they are exported, a government notice showed on Tuesday, after Indian-made cough syrups were linked to the deaths of dozens of children in Gambia and Uzbekistan. Any cough syrup must have a certificate of analysis issued by a government laboratory before it is exported, effective June 1, the government said in a notice dated May 22 and shared by the health ministry on Tuesday. India's $41 billion pharmaceutical industry is one of the biggest in the world but its reputation was shaken after the World Health Organization (WHO) found toxins in cough syrups made by three Indian companies. Syrups made by two of these companies were linked to the deaths of 70 children in Gambia and 19 in Uzbekistan last year. "Cough syrup shall be permitted to be exported subject to the export sample being tested and production of certificate of analysis," said the notice issued by the trade ministry. The health ministry did not immediately respond to a query on whether testing would be required for cough syrups sold in the domestic market.

Working in an office environment can be hazardous to your health. From sitting on a chair all day to exposure to harmful chemicals, many potential health hazards can occur in the workplace. While some health hazards are out of your control, there are many things you can do to help prevent them. Here are seven efficient ways to prevent health hazards at the workplace: 1. TAKE HEALTH AND SAFETY TRAINING Health and safety training is an efficient way to prevent health hazards at the workplace for several reasons. First, it helps employees to be aware of potential hazards in their work environment. This knowledge can then be used to take steps to avoid or control these hazards. Second, health and safety training provides employees with the skills and knowledge necessary to identify and report potential health hazards, especially those working in medical laboratories with frequent exposure to blood, chemicals, and other pathogens. This can help to ensure that any problems are quickly addressed and corrected. Finally, health and safety training helps to create a culture of safety in the workplace. This safety culture can encourage employees to take personal responsibility for their own health and safety, as well as the health and safety of their coworkers.

Microplates are an important part of many laboratory experiments. They are often used to measure the results of a process or to test a product. When working with microplates, it is important to use the right closure and sealing method to ensure accurate results. This article will discuss the different types of closures and seals available, as well as how to choose the right one for your needs. HEAT SEALING METHOD One of the most common methods for sealing microplates is the heat seal method. This method uses a heating element to melt the top layer of the plate, which then bonds to the bottom layer. Heat sealing is a quick and easy way to seal a microplate, and it is often used for plates that will be stored for long periods. For this reason, heat sealing is the preferred method for sealing storage plates. Heat sealing is also one of the most cost-effective methods for sealing microplates. If you are interested to learn more about heat sealing, you may be surprised to find that there are many pieces of heat sealing equipment for sale at a very reasonable price. You just need to take the time to find the right one for your needs. As much as possible, choose the one with adjustable temperature settings so you can find the perfect heat for your microplates. More often than not, 225 degrees Fahrenheit is the ideal temperature for heat sealing.

An Indian court has sentenced two pharmaceutical company executives to two-and-half years in jail for exporting substandard drugs to Vietnam a decade ago, months after the WHO linked their cough syrups to the deaths of children in Gambia. India suspended production at Maiden Pharmaceuticals in October last year for violations of manufacturing standards after the World Health Organization said four of its cough syrups may have killed dozens of children in Gambia. The company has denied its drugs were at fault for the deaths in Gambia and tests by an Indian government laboratory found there were no toxins in them. The company had been facing legal difficulties for years over suspected shoddy products. A court in Sonipat, near New Delhi, where Maiden has its main production facility, ordered jail for company founder Naresh Kumar Goel and technical director M.K. Sharma for exporting heartburn medicine "not of standard quality" to Vietnam.

One type of bacteria found in the gut may contribute to the development of Type 2 diabetes, while another may protect from the disease, according to early results from an ongoing, prospective study led by investigators at Cedars-Sinai. The study, published in the peer-reviewed journal Diabetes, found people with higher levels of a bacterium called Coprococcus tended to have higher insulin sensitivity, while those whose microbiomes had higher levels of the bacterium Flavonifractor tended to have lower insulin sensitivity. Mark Goodarzi, the director of the Endocrine Genetics Laboratory at Cedars-Sinai in Los Angeles, California, is leading an ongoing study that is following and observing people at risk for diabetes to learn whether those with lower levels of these bacteria develop the disease. "The big question we're hoping to address is: Did the microbiome differences cause diabetes, or did diabetes cause the microbiome differences?" said Goodarzi, who is the senior author of the study and principal investigator of the multicenter study called Microbiome and Insulin Longitudinal Evaluation Study (MILES).

British drugmaker AstraZeneca says it's confident that its new version of COVID-19 antibody treatment could protect immunocompromised patients against all known virus variants. Laboratory studies show the antibody, called AZD3152, neutralises all known variants of COVID-19 and AstraZeneca has support from regulators to make the treatment available by the end of this year, the company's vaccines head Iskra Reic said on Tuesday (April 18). AstraZeneca plans, pending more positive data and regulatory approval, to make the antibody available by the end of 2023. These types of therapies are most needed for people with compromised immune systems, either because of underlying conditions or because they are undergoing immune suppressing treatments. They account for nearly 2% of the global population. AstraZeneca's AZD3152, it new COVID-19 antibody, was acquired through a $157 million deal last year with British biotech start-up RQ Bio. The British drugmaker will likely make future investments like its current partnerships with RQ Bio but did not have any deals to announce, said Reic, a long-time AstraZeneca executive who has led the company's vaccines and immune therapies unit since it was formed in late 2021, during the pandemic.

With 118 new cases confirmed by the UK Health Security Agency (UKHSA), the total number of measles cases reported in England since 1 October 2023 has gone up to 465. According to the latest data published by the agency, West Midlands continues to see a disproportionately high rate of infections, with a sharp rise in case numbers over the last six weeks, mainly driven by cases in Birmingham. In England, there were 17 laboratory-confirmed measles cases in October, 42 in November, 161 in December, 240 in January 2024. Five more cases were confirmed last week, according to the measles statistics updated by UKHSA on 8 February. More than 70 per cent (329 of 465) of total confirmed cases were reported from the West Midlands, 13 per cent (62 of 465) from London, seven per cent (32 of 465) in Yorkshire and The Humber, and the remaining cases from other regions of England.

Hilleman laboratories vaccine research and science programs are focused on turning innovative science into practical solutions for developing countries.

Global Surgery (GOS) is a bimonthly open access journal with a comprehensive peer review policy, and a rapid publication process. GOS features the very best in clinical and laboratory-based research on all aspects of surgical procedures and interventions. Patient care around the peri-operative period and patient outcomes post surgery are key topics for the journal.

Epic Sciences has announced an agreement with Laboratory Corporation of America Holdings (LabCorp) to expedite sample processing for Epic's circulating tumor cell (CTC) technology to support European clinical trials.